Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Neoplasm
• Breast Cancer
• Estrogen Receptor Negative
• HER2 Neu Negative
• Mesothelioma
• Non-small Cell Lung Cancer
• Progesterone Receptor Negative
• Renal Cell Cancer
• Stage Iiia Breast Cancer
• Stage Iiia Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer
• Stage Iiic Breast Cancer
• Triple-negative Breast Carcinoma

Snippet

Sponsor: Andrei Iagaru | Conditions: B-Cell Neoplasm, Estrogen Receptor Negative | Phase 2 | Status: COMPLETED | Results posted: 2019-01-03